-
EP3237413
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3237413
| EP3237413 - COMPOSITIONS OF FATOSTATIN BASED HETEROCYCLIC COMPOUNDS AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.08.2019 Database last updated on 19.10.2024 | |
| Former | Request for examination was made Status updated on 29.09.2017 | ||
| Former | The international publication has been made Status updated on 25.07.2017 | Most recent event Tooltip | 09.08.2019 | Application deemed to be withdrawn | published on 11.09.2019 [2019/37] | Applicant(s) | For all designated states FGH Biotech 414 Thamer Circle Houston, TX 77024 / US | [2017/44] | Inventor(s) | 01 /
UESUGI, Motonari 9-1 Takamiya Asahioka Neyagoawa-shi Osaka 572-0867 / JP | 02 /
HUFF, Joel 179 Spiritual Pass Spring Branch, TX 78070 / US | [2017/44] | Representative(s) | Petty, Catrin Helen, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2017/44] | Application number, filing date | 15873775.9 | 23.12.2015 | [2017/44] | WO2015US00221 | Priority number, date | US201462096121P | 23.12.2014 Original published format: US 201462096121 P | [2017/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016105491 | Date: | 30.06.2016 | Language: | EN | [2016/26] | Type: | A1 Application with search report | No.: | EP3237413 | Date: | 01.11.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.06.2016 takes the place of the publication of the European patent application. | [2017/44] | Search report(s) | International search report - published on: | RU | 30.06.2016 | (Supplementary) European search report - dispatched on: | EP | 16.08.2018 | Classification | IPC: | C07D417/04, C07D417/14, A61K31/422, A61K31/427, A61K31/454, A61K31/4545, A61K31/497, A61P3/06, A61P35/00 | [2018/23] | CPC: |
A61K31/44 (EP,US);
A61K31/41 (EP,US);
A61K31/422 (EP,US);
A61K31/427 (EP,US);
A61K31/454 (EP,US);
A61K31/4545 (EP,US);
A61K31/497 (EP,US);
A61P3/06 (EP,US);
A61P35/00 (EP,US);
C07D401/04 (EP,US);
C07D401/14 (EP,US);
C07D413/04 (EP,US);
|
| Former IPC [2017/44] | C07D417/04, C07D417/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/44] | Title | German: | ZUSAMMENSETZUNGEN VON FATOSTATINBASIERTEN HETEROCYCLISCHEN VERBINDUNGEN UND VERWENDUNGEN DAVON | [2017/44] | English: | COMPOSITIONS OF FATOSTATIN BASED HETEROCYCLIC COMPOUNDS AND USES THEREOF | [2017/44] | French: | COMPOSITIONS DE COMPOSÉS HÉTÉROCYCLIQUES À BASE DE FATOSTATINE ET UTILISATIONS ASSOCIÉES | [2017/44] | Entry into regional phase | 24.07.2017 | National basic fee paid | 24.07.2017 | Search fee paid | 24.07.2017 | Designation fee(s) paid | 24.07.2017 | Examination fee paid | Examination procedure | 24.07.2017 | Amendment by applicant (claims and/or description) | 24.07.2017 | Examination requested [2017/44] | 24.07.2017 | Date on which the examining division has become responsible | 15.03.2019 | Application deemed to be withdrawn, date of legal effect [2019/37] | 26.04.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2019/37] | Fees paid | Renewal fee | 27.12.2017 | Renewal fee patent year 03 | 31.12.2018 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [X]US2014045845 (HOEGBERG MARITA [SE], et al) [X] 1-17 * , abstract, paragraphs [0003]-[0011], [0013]-[0021],[0060]-[0079], [0081]-[0101], table 3, figures, examples, paragraphs [0198]-[0235], claims *; | [X]US2014038984 (UESUGI MOTONARI [JP], et al) [X] 1-16 * , abstract, paragraphs [0004]-[0020], [0055]-[0074], [0076]-[0095], examples, tables, claims *; | [X]WO2008097835 (BAYLOR COLLEGE MEDICINE [US], et al) [X] 1-17 * , abstract, paragraphs [0003]-[0019], [0053]-[0153], examples, figures, claims *; | [X]US2014235646 (UESUGI MOTONARI [JP], et al) [X] 1-15, 18-19 * , abstract, paragraphs [0002]-[0015], [0062]-[0072],[0074]-[0093], figures, table 3, examples, claims *; | [X]WO2006024642 (CLARIANT INT LTD [CH], et al) [X] 1-3, 14 * , abstract, formulas (V), (VI), (VIII), pages 4-6, compounds of formulas (III), (IV), page 11, compounds of formulas (VII), (VIII), examples 1, 3, 5-10 * | [X] - EKNATH BELLALE et al., "Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system", Journal of Medicinal Chemistry, (20140626), vol. 57, no. 15, pages 6572 - 6582, XP055386372 [X] 1-3, 14 * , especially page 6573, fig.l, tables 1-3, compounds 45, 46 and 48 * DOI: http://dx.doi.org/10.1021/jm500833f |